BPA for drug testing services
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- 2031ZA23A00011
- Awardee
-
Comprehensive Drug Testing, Inc. UEI YM54JZGNDGC5
- Awarding agency
-
Bureau of Engraving and Printing
Department of the Treasury
- Task orders
- 4 $162,960 obligated
Award facts
- Combined order value
- $162,960 Current and potential, with all options
- Last date to order 62% complete
- IDV ceiling 50% used
- $325,825.00
- Maximum order
- $325,825.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this IDV
The Bureau of Engraving and Printing established a Blanket Purchase Agreement with Comprehensive Drug Testing, Inc., a woman-owned small business, on October 1, 2023, with a ceiling of $325,825 and an ultimate completion date of September 30, 2028.
The BPA covers standardized drug screening services, including five-panel urine tests, specimen validations, and medical review officer support, to support the agency's workplace health and safety compliance programs. Place of performance includes BEP facilities in Washington, DC, Saginaw, Texas (Washington Currency Facility), and Fort Worth, Texas (Western Currency Facility).
Recent BPA calls issued under this agreement include a $62,075 call awarded November 26, 2024, for drug testing services from December 1, 2024 through September 30, 2025 at the Washington, DC facility; a $45,405 call under total small business set-aside awarded July 1, 2024, for services through November 30, 2024; a $3,315 call awarded December 23, 2024, to ratify an unauthorized commitment for services performed in May and June 2024; and a $52,165 call under total small business set-aside awarded March 11, 2026, with completion by September 30, 2026.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| DCF drug testing BPA call | Bureau of Engraving and Printing | $52,165 | |
| The purpose of this award is to ratify an unauthorized commitment for | Bureau of Engraving and Printing | $3,315 | |
| Drug testing services to be performed from december 1, 2024 through september 30, 2025. | Bureau of Engraving and Printing | $62,075 | |
| Drug testing | Bureau of Engraving and Printing | $45,405 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 2031ZA23A00011?
2031ZA23A00011 was awarded to Comprehensive Drug Testing, Inc. by Bureau of Engraving and Printing (Department of the Treasury) on October 1, 2023.
How much is contract 2031ZA23A00011 worth?
Orders under 2031ZA23A00011 have obligated $162,960. 2031ZA23A00011's own ceiling is $325,825. A single order can be worth up to $325,825.
How many orders have been placed under contract 2031ZA23A00011?
4 orders have been placed under 2031ZA23A00011, the latest on March 11, 2026.
Who can order from contract 2031ZA23A00011?
2031ZA23A00011 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV